Mirabelli Christopher Insider Trades

Insider Trading History

Track insider trading activity for Mirabelli Christopher. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Leap Therapeutics
Leap Therapeutics LPTX
Chairman Of The Board
Holding Value $21.2k 27,586 shares
Last Trade
Mar 28, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.12k 22,500 shares
$0.32
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Chairman Of The Board
Holding Value $0 0 shares
Last Trade
Mar 28, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.12k 22,500 shares
$0.32
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Chairman Of The Board
Holding Value $16.1k 20,914 shares
Last Trade
Mar 28, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.14k 6,672 shares
$0.32
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Chairman Of The Board
Holding Value $0 0 shares
Last Trade
Nov 13, 2024 Sale (In The Money)Reported as In The Money on SEC Form 4.
$6.02k 2,136 shares
$2.82
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Chairman Of The Board
Holding Value $522k 678,456 shares
Last Trade
Nov 13, 2024 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$6.02k 2,136 shares
$2.82
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Director
Holding Value $65.4k 85,000 shares
Last Trade
Oct 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$208k 85,000 shares
$2.45
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Chairman Of The Board
Holding Value $65.4k 85,000 shares
Last Trade
Jan 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$228k 85,000 shares
$2.68
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Chairman Of The Board
Holding Value $3.91k 5,086 shares
Last Trade
Jan 26, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.2k 5,000 shares
$2.44
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Chairman Of The Board
Holding Value $0 0 shares
Last Trade
Jan 26, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.2k 5,000 shares
$2.44
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Chairman Of The Board
Holding Value $53.9k 70,000 shares
Last Trade
Aug 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$155k 70,000 shares
$2.21
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Director
Holding Value $385k 500,000 shares
Last Trade
Mar 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17M 500,000 shares
$34.00
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Director
Holding Value $154k 200,000 shares
Last Trade
Sep 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.6M 200,000 shares
$143.00
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
10% owner
Holding Value $173k 225,000 shares
Last Trade
Jan 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.7M 225,000 shares
$194.00
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
10% owner
Holding Value $23.1k 30,000 shares
Last Trade
May 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.86M 30,000 shares
$162.00
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Director
Holding Value $0 0 shares
Last Trade
Feb 09, 2021 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$151M 571,428 shares
$265.00
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Director
Holding Value $8.88k 11,544 shares
Last Trade
Feb 09, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$3.06M 11,544 shares
$265.00
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
10% owner
Holding Value $115k 150,000 shares
Last Trade
Jan 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$38.6M 150,000 shares
$257.00
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
10% owner, Chairman Of The Board
Holding Value $57.7k 75,000 shares
Last Trade
Aug 10, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.7M 75,000 shares
$196.50
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
10% owner
Holding Value $38.5k 50,000 shares
Last Trade
Apr 09, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.45M 50,000 shares
$169.00
$0.77
Yumanity Therapeutics
Yumanity Therapeutics YMTX
10% owner
Holding Value $0 0 shares
Last Trade
Feb 17, 2016 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$920k 160,000 shares
$5.75
$1.89

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up